Cancer chemotherapy and biotherapy : principles and practice /
Saved in:
Edition: | Fifth edition. |
---|---|
Imprint: | Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, [2011] ©2011 |
Description: | 1 online resource (836 pages) : illustrations (some color) |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/13441441 |
Table of Contents:
- Section 1. Basic Principles Of Cancer Treatment
- 1. Clinical Strategies for Cancer Treatment: The Role of Drugs
- 2. Target Identification and Drug Discovery
- 3. Clinical Drug Development and Approval for Marketing
- 4. Principles of Pharmacokinetics
- 5. Special Aspects of Brain Tumor Chemotherapy
- 6. Pharmacogenetics
- 7. Barriers to Drug Delivery
- Section 2. Cytotoxic Agents
- 8. Antifolates
- 9. Fluoro-pyrimidines
- 10. Cytidine Analogues
- 11. Purine Analogues
- 12. Hydroxyurea
- 13. Antimitotic Drugs
- 14. Alkylating Agents (Including Methylating Agents)
- 15. Platinum Analogues
- 16. Antitumor Antibiotics (Including Bleomycin)
- 17. Topoisomerase I Inhibitors
- 18. Topoisomerase II Inhibitors: Anthracyclines
- 19. Topoisomerase II Inhibitors: Etoposide, Teniposide
- 20. L-Asparaginase
- Section 3. Molecularly Targeted Therapies
- 21. Proteosome Inhibitors
- 22. HDAC Inhibitors
- 23. Differentiating Agents (Retinoids)
- 24. Arsenic Trioxide
- 25. Monoclonal Antibodies: Discovery & Development
- 26. Anti-angiogenic Agents (Including MonAB)
- 27. Anti-EGFR Therapies (Including MonAB)
- 28. Anti-her 2 Therapies
- 29. Intracellular Signal Inhibitors (bcr-abl)
- 30. Signal Transduction Inhibitors in Development
- 31. Inhibitors of the PI3k Pathway & Mitotic Kinase
- Section 4. Immunologic Agents
- 32. Interferon and Cytokines
- 33. Vaccines
- 34. Adoptive Cellular Therapies
- 35. Immuno-modulatory Drugs (IMIDS, Anti-CTLA4)
- Section 5. Hormonal Therapy
- 36. Hormonal Therapy of Breast Cancer
- 37. GNRH Agonists and Anti-Androgens
- Section 6. Supportive Care
- 38. Pain Management in Cancer Patients
- 39. Colony Stimulating Factors
- 40. Anti-nausea Medications
- 41. Bone Loss Modulators
- 42. Intravenous Access and Catheter Management
- Section 7. Survivorship
- 43. Monitoring for Late Side Effects of Chemotherapy